Conditions: Diabetes Mellitus, Type 2 Hypertension
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 825
Healthy volunteers: no

Brief summary:
This trial will evaluate safety and efficacy of BI 10773 in hypertensive patients with type 2 diabetes. Since hyperglycaemia and hypertension are key risk factors for both micro- and macrovascular complications, assessment of both glucose and blood pressure lowering effects of BI 10773 in hypertensive patients with type 2 diabetes could provide clinically highly relevant, new information for the use of BI 10773

Detailed description:

Arms:
arm 1: BI 10773 low dose once daily arm 2: BI 10773 high dose once daily arm 3: Placebo tablets matching BI 10773

Interventions: intervention 1: Placebo intervention 2: BI 10773 intervention 3: Placebo intervention 4: BI 10773 intervention 5: Placebo intervention 6: Placebo
Intervention descriptions: intervention 1: Placebo matching BI 10773 low dose intervention 2: BI 10773 high dose once daily intervention 3: Placebo matching BI 10773 low dose intervention 4: BI 10773 low dose once daily intervention 5: Placebo matching BI 10773 high dose intervention 6: Placebo matching BI 10773 high dose

Protocol document: